Diabetes & Metabolism Journal

Moon Kyu Lee (Lee MK)

6 Articles

Clinical Diabetes & Therapeutics
Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial: Tae Jung Oh, Jae Myung Yu, Kyung Wan Min, Hyun Shik Son, Moon Kyu Lee, Kun Ho Yoon, Young Duk Song, Joong Yeol Park, In Kyung Jeong, Bong Soo Cha, Yong Seong Kim, Sei Hyun Baik, In Joo Kim, Doo Man Kim, Sung Rae Kim, Kwan Woo Lee, Jeong Hyung Park, In Kyu Lee, Tae Sun Park, Sung Hee Choi, Sung Woo Park; Diabetes Metab J. 2019;43(3):276-286. Published online December 7, 2018; DOI: https://doi.org/10.4093/dmj.2018.0051

7,903 View
109 Download
15 Web of Science
14 Crossref

Background

Combination of metformin to reduce the fasting plasma glucose level and an α-glucosidase inhibitor to decrease the postprandial glucose level is expected to generate a complementary effect. We compared the efficacy and safety of a fixed-dose combination of voglibose plus metformin (vogmet) with metformin monotherapy in drug-naïve newly-diagnosed type 2 diabetes mellitus.

Methods

A total of 187 eligible patients aged 20 to 70 years, with a glycosylated hemoglobin (HbA1c) level of 7.0% to 11.0%, were randomized into either vogmet or metformin treatments for 24 weeks. A change in the HbA1c level from baseline was measured at week 24.

Results

The reduction in the levels of HbA1c was −1.62%±0.07% in the vogmet group and −1.31%±0.07% in the metformin group (P=0.003), and significantly more vogmet-treated patients achieved the target HbA1c levels of <6.5% (P=0.002) or <7% (P=0.039). Glycemic variability was also significantly improved with vogmet treatment, estimated by M-values (P=0.004). Gastrointestinal adverse events and hypoglycemia (%) were numerically lower in the vogmet-treated group. Moreover, a significant weight loss was observed with vogmet treatment compared with metformin (−1.63 kg vs. −0.86 kg, P=0.039).

Conclusion

Vogmet is a safe antihyperglycemic agent that controls blood glucose level effectively, yields weight loss, and is superior to metformin in terms of various key glycemic parameters without increasing the risk of hypoglycemia.

Citations

Citations to this article as recorded by

Phytochemical analysis and antihyperglycemic activity of Castilleja arvensis
Mónica Aideé Díaz-Román, Juan José Acevedo-Fernández, Gabriela Ávila-Villarreal, Elizabeth Negrete-León, A. Berenice Aguilar-Guadarrama
Fitoterapia.2024; 174: 105839. CrossRef
Efficacy and Safety of DPP-4 Inhibitors and Metformin Combinations in Type 2 Diabetes: A Systematic Literature Review and Network Meta-Analysis
Rongping Chen, Jing Li, Danqi Chen, Weiheng Wen, Susu Zhang, Jitong Li, Yuting Ruan, Zhen Zhang, Jia Sun, Hong Chen
Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 2471. CrossRef
Metformin-Associated Gastrointestinal Adverse Events Are Reduced by Probiotics: A Meta-Analysis
Izabela Szymczak-Pajor, Józef Drzewoski, Sylwia Wenclewska, Agnieszka Śliwińska
Pharmaceuticals.2024; 17(7): 898. CrossRef
YAP/TAZ axis was involved in the effects of metformin on breast cancer
Yu Xu, Hongke Cai, Yuanfeng Xiong, Li Tang, Longjiang Li, Li Zhang, Yi Shen, Yongqiang Yang, Ling Lin, Jiayi Huang
Journal of Chemotherapy.2023; 35(7): 627. CrossRef
Diabetes Remission
Ashok Kumar, Shubha Laxmi Margekar, Ravi Kumar
Indian Journal of Medical Specialities.2023; 14(1): 3. CrossRef
Analysis of Reports Sent to the Portuguese Pharmacovigilance System and Published Literature Regarding the Safety of Metformin in the Elderly
Beatriz Esteves, Cristina Monteiro, Ana Paula Coelho Duarte
Healthcare.2023; 11(15): 2197. CrossRef
Rapid prediction method of α-Glycosidase inhibitory activity of Coreopsis tinctoria extract from different habitats by near infrared spectroscopy
Xiaogang He, Xiang Han, Jiaping Yu, Yulong Feng, Ganghui Chu
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.2022; 268: 120601. CrossRef
Insulin autoimmune syndrome in patients with type 2 diabetes: A report of two cases
Y. Shin, T.J. Oh, S.H. Choi, H.C. Jang
Diabetes & Metabolism.2021; 47(1): 101115. CrossRef
Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study
Jun Sung Moon, Sunghwan Suh, Sang Soo Kim, Heung Yong Jin, Jeong Mi Kim, Min Hee Jang, Kyung Ae Lee, Ju Hyung Lee, Seung Min Chung, Young Sang Lyu, Jin Hwa Kim, Sang Yong Kim, Jung Eun Jang, Tae Nyun Kim, Sung Woo Kim, Eonju Jeon, Nan Hee Cho, Mi-Kyung Ki
Diabetes & Metabolism Journal.2021; 45(5): 675. CrossRef
Quantifying Remission Probability in Type 2 Diabetes Mellitus
Sanjay Kalra, Ganapathi Bantwal, Nitin Kapoor, Rakesh Sahay, Saptarshi Bhattacharya, Beatrice Anne, Raju A Gopal, Sunil Kota, Ashok Kumar, Ameya Joshi, Debmalya Sanyal, Mangesh Tiwaskar, Ashok Kumar Das
Clinics and Practice.2021; 11(4): 850. CrossRef
The effect of voglibose on metabolic profiles in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials
Peyman Nowrouzi-Sohrabi, Reza Tabrizi, Shahla Rezaei, Fatemeh Jafari, Kamran Hessami, Mehdi Abedi, Mohammad Jalali, Pedram Keshavarzi, Saeed Shahabi, Ali Asghar Kolahi, Kristin Carson-Chahhoud, Amirhossein Sahebkar, Saeid Safiri
Pharmacological Research.2020; 159: 104988. CrossRef
Role of Intestinal Microbiota in Metabolism of Voglibose In Vitro and In Vivo
Mahesh Raj Nepal, Mi Jeong Kang, Geon Ho Kim, Dong Ho Cha, Ju-Hyun Kim, Tae Cheon Jeong
Diabetes & Metabolism Journal.2020; 44(6): 908. CrossRef
Response: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes metab J 2019;43;276-86)
Tae Jung Oh, Sung Hee Choi
Diabetes & Metabolism Journal.2019; 43(4): 547. CrossRef
Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2019;43;276-86)
Hannah Seok, Tae Seo Sohn
Diabetes & Metabolism Journal.2019; 43(4): 545. CrossRef

Erratum: Corrected Sentence. The Appropriateness of the Length of Insulin Needles Based on Determination of Skin and Subcutaneous Fat Thickness in the Abdomen and Upper Arm in Patients with Type 2 Diabetes: Kang Hee Sim, Moon Sook Hwang, Sun Young Kim, Hye Mi Lee, Ji Yeun Chang, Moon Kyu Lee; Diabetes Metab J. 2014;38(3):244-244. Published online June 17, 2014; DOI: https://doi.org/10.4093/dmj.2014.38.3.244

3,073 View
41 Download

PDF PubReader

The Appropriateness of the Length of Insulin Needles Based on Determination of Skin and Subcutaneous Fat Thickness in the Abdomen and Upper Arm in Patients with Type 2 Diabetes: Kang Hee Sim, Moon Sook Hwang, Sun Young Kim, Hye Mi Lee, Ji Yeun Chang, Moon Kyu Lee; Diabetes Metab J. 2014;38(2):120-133. Published online April 18, 2014; DOI: https://doi.org/10.4093/dmj.2014.38.2.120

5,979 View
131 Download
25 Web of Science
25 Crossref

Abstract PDF PubReader

Background

Longer needle and complicated insulin injection technique such as injecting at a 45-degree angle and making skinfolds may decrease patient compliance to insulin injection therapy. In this light, shorter insulin needles have been recently developed. However, it is necessary to ascertain that such shorter needles are appropriate for Korean patients with diabetes as well.

Methods

First, the diverse demographic and diabetic features of 156 Korean adults with diabetes were collected by a questionnaire and a device unit of body fat measurement. The skin and subcutaneous fat thicknesses of each subject were measured by Ultrasound device with a 7- to 12-MHz probe. Data were analyzed using analysis of variance and multiple linear regression.

Results

The mean skin thickness was 2.29±0.37 mm in the abdomen and 2.00±0.34 mm in the upper arms, and the mean subcutaneous fat thickness was to 10.15±6.54 mm in the abdomen and 5.50±2.68 mm in the upper arms. Our analysis showed that the factors affecting the skin thickness of the abdomen and upper arms were gender and body mass index (BMI), whereas the factors influencing the subcutaneous fat thickness in the abdomen were gender and BMI, and the factors influencing the subcutaneous fat thickness in the upper arms were gender, BMI, and age. Insulin fluids may not appear to be intradermally injected into the abdomen and upper arms at any needle lengths. The risk of intramuscular injection is likely to increase with longer insulin needles and lower BMI.

Conclusion

It is recommended to fully inform the patients about the lengths of needles for insulin injections. As for the recommended needle length, the findings of this study indicate that needles as short as 4 mm are sufficient to deliver insulin for Korean patients with diabetes.

Citations

Citations to this article as recorded by

Ultrasonographic features of the skin and subcutis: correlations with the severity of breast cancer–related lymphedema
Ji Youn Park, Jae Yong Jeon, Seungwoo Cha
Ultrasonography.2024; 43(4): 284. CrossRef
An Implantable Magnetic Drive Mechanism for Non-Invasive Arteriovenous Conduit Blood Flow Control
Nicholas A. White, Sander L. van der Kroft, Koen E.A. van der Bogt, Timo J.C. Oude Vrielink, Christian Camenzuli, Jean Calleja-Agius, Juan A. Sánchez-Margallo, Francisco M. Sánchez-Margallo, Huybert J.F. van de Stadt, Jenny Dankelman, Joris I. Rotmans, Ti
IEEE Transactions on Biomedical Engineering.2024; 71(8): 2379. CrossRef
Quad-Band 1 × 4 Linear MIMO Antenna for Millimeter-Wave, Wearable and Biomedical Telemetry Applications
Rakesh N. Tiwari, K. Geetha Malya, Girigari Nandini, P. Baby Nikhitha, Deepti Sharma, Prabhakar Singh, Pradeep Kumar
Sensors.2024; 24(14): 4427. CrossRef
Inadvertent intramuscular injection risk with subcutaneous insulin injections and risk predictors in adults: a cross-sectional sonographic study
U. A. Liyanage, Y. Mathangasinghe, C. K. Liyanage, E. S. Wijewickrama, D. Mahathanthila, A. J. Dharmawansa, S. Jeyerajesingham, D. S. Warapitiya, M. D. M. S. Wijayabandara, B. C. T. A. N. W. M. R. C. S. Kempitiya, A. Aravinthan, L. M. D. T. Jayasekara, N.
International Journal of Diabetes in Developing Countries.2023; 43(5): 731. CrossRef
COVID-19 vaccination and the skin to deltoid muscle distance in adults with diabetes
Marjan Doppen, Ali Mirjalili, Matire Harwood, Allie Eathorne, Irene Braithwaite, Jonathan Bong, Louis Kirton, Ruth Semprini, Mark Weatherall, Alex Semprini, Ciléin Kearns, Melissa Black, Stacey Kung, Michaela Walton, Richard Beasley, Thomas Hills
Vaccine: X.2023; 13: 100248. CrossRef
Integration of capillaric strain sensors toward recognition of human movements
Hudson Gasvoda, Nick Cmager, Rana Altay, Ju Young Lee, I. Emre Araci
Sensors & Diagnostics.2023; 2(1): 212. CrossRef
What variables should inform needle length choice for deltoid intramuscular injection? A systematic review
Ciléin Kearns, Claire Houghton, Emily Dickinson, Lee Hatter, Pepa Bruce, Srinidhi Krishnamoorthy, Mark Weatherall, Thomas Hills, Marjan Doppen, Seyed Ali Mirjalili, Richard Beasley
BMJ Open.2023; 13(1): e063530. CrossRef
Investigation of appropriate needle length considering skin thickness with the real injection posture for insulin injections in diabetic patients
Aya Torii-Goto, Kana Hirai, Yuri Inukai, Yoshimi Hoshina, Kazumi Shiomi, Junko Ito, Masae Yoshikawa
Journal of Pharmaceutical Health Care and Sciences.2023;[Epub] CrossRef
Machine Learning-Based Prediction of Abdominal Subcutaneous Fat Thickness During Pregnancy
Moon Sook Hwang, Eunjeong Song, Jeonghee Ahn, Seungmi Park
Metabolic Syndrome and Related Disorders.2023; 21(9): 479. CrossRef
Human continuous glucose monitors for measurement of glucose in dairy cows
M.K.H. Byrd, A.G. Arneson, D.R. Soffa, J.W. Stewart, M.L. Rhoads
JDS Communications.2022; 3(1): 78. CrossRef
A finite element model of abdominal human tissue for improving the accuracy in insulin absorption assessment: A feasibility study
Pasquale Arpaia, Davide Cuneo, Sabrina Grassini, Francesca Mancino, Simone Minucci, Nicola Moccaldi, Isabella Sannino
Measurement: Sensors.2021; 18: 100218. CrossRef
Abdominal skin subcutaneous fat thickness over the gestational period in Korean pregnant women: a descriptive observational study
Moon Sook Hwang
Korean Journal of Women Health Nursing.2021; 27(4): 318. CrossRef
User experience for manual injection of 2 mL viscous solutions is enhanced by a new prefillable syringe with a staked 8 mm ultra-thin wall needle
Aurélie Pager, Anne Combedazou, Karen Guerrero, Tzvetelina Tzvetkova-Chevolleau, Didier Morel, Cécile Frolet, Stanislav Glezer
Expert Opinion on Drug Delivery.2020; 17(10): 1485. CrossRef
Evaluating the Impact of Human Factors and Pen Needle Design on Insulin Pen Injection
Christopher Rini, Bruce C. Roberts, Didier Morel, Rick Klug, Benjamin Selvage, Ronald J. Pettis
Journal of Diabetes Science and Technology.2019; 13(3): 533. CrossRef
Subcutaneous Injection of Drugs: Literature Review of Factors Influencing Pain Sensation at the Injection Site
Iris Usach, Rafael Martinez, Teodora Festini, José-Esteban Peris
Advances in Therapy.2019; 36(11): 2986. CrossRef
The Injection Technique Factor: What You Don’t Know or Teach Can Make a Difference
Laurence J. Hirsch, Kenneth W. Strauss
Clinical Diabetes.2019; 37(3): 227. CrossRef
Factors associated with removal difficulties of etonogestrel-containing contraceptive implants (Nexplanon®)
Julien Chevreau, David Krief, Osama Abou Arab, Mickaël Zitoun, Arthur Foulon, Fabrice Sergent, Jean Gondry
European Journal of Obstetrics & Gynecology and Reproductive Biology.2018; 224: 81. CrossRef
Insulin Injection Technique in China Compared with the Rest of the World
Zhenqiang Song, Xiaohui Guo, Linong Ji, Xiao Huang, Laurence J. Hirsch, Kenneth W. Strauss
Diabetes Therapy.2018; 9(6): 2357. CrossRef
Ultrasound-guided measurement of skin and subcutaneous tissue thickness in children with diabetes and recommendations for giving insulin injections
Soo Ting Joyce Lim, Yuen Ching Angela Hui, Pei Kwee Lim, Chin Choo Evelyn Lim, Yen Yen Chia, Rashida Farhad Vasanwala
Journal of Clinical & Translational Endocrinology.2018; 12: 26. CrossRef
Comment on the New Indian Injection Technique Recommendations: Critical Appraisal of the Real-World Implementation of the Current Guidelines
Felice Strollo, Sandro Gentile
Diabetes Therapy.2017; 8(3): 507. CrossRef
Worldwide Injection Technique Questionnaire Study
Anders H. Frid, Laurence J. Hirsch, Astrid R. Menchior, Didier R. Morel, Kenneth W. Strauss
Mayo Clinic Proceedings.2016; 91(9): 1212. CrossRef
Skin and subcutaneous tissue thickness at insulin injection sites in Chinese diabetes patients: Clinical implications
W. Wang, X. Guo, G. Shen, G. Bai, Z. Wei, J. Liu, L. Hirsch, K. Strauss
Diabetes & Metabolism.2016; 42(5): 374. CrossRef
New Insulin Delivery Recommendations
Anders H. Frid, Gillian Kreugel, Giorgio Grassi, Serge Halimi, Debbie Hicks, Laurence J. Hirsch, Mike J. Smith, Regine Wellhoener, Bruce W. Bode, Irl B. Hirsch, Sanjay Kalra, Linong Ji, Kenneth W. Strauss
Mayo Clinic Proceedings.2016; 91(9): 1231. CrossRef
Le tissu sous-cutané et l’insuline : Une cohabitation délicate Revue de la littérature
K. Strauss, S. Halimi
Médecine des Maladies Métaboliques.2015; 9(5): 504. CrossRef
Subcutaneous Injection Depth Does Not Affect the Pharmacokinetics or Glucodynamics of Insulin Lispro in Normal Weight or Healthy Obese Subjects
Amparo de la Peña, Kwee P. Yeo, Helle Linnebjerg, Edward Catton, Shobha Reddy, Patricia Brown-Augsburger, Linda Morrow, Debra A. Ignaut
Journal of Diabetes Science and Technology.2015; 9(4): 824. CrossRef

Education as Prescription for Patients with Type 2 Diabetes Mellitus: Compliance and Efficacy in Clinical Practice: Mi Yeon Kim, Sunghwan Suh, Sang-Man Jin, Se Won Kim, Ji Cheol Bae, Kyu Yeon Hur, Sung Hye Kim, Mi Yong Rha, Young Yun Cho, Myung-Shik Lee, Moon Kyu Lee, Kwang-Won Kim, Jae Hyeon Kim; Diabetes Metab J. 2012;36(6):452-459. Published online December 12, 2012; DOI: https://doi.org/10.4093/dmj.2012.36.6.452

4,931 View
34 Download
12 Crossref

Abstract PDF PubReader

Background

Diabetes self-management education has an important role in diabetes management. The efficacy of education has been proven in several randomized trials. However, the status of diabetes education programs in real Korean clinical practice has not yet been evaluated in terms of patient compliance with the education prescription.

Methods

We retrospectively analyzed clinical and laboratory data from all patients who were ordered to undergo diabetes education during 2009 at Samsung Medical Center, Seoul, Korea (n=2,291). After excluding ineligible subjects, 588 patients were included in the analysis.

Results

Among the 588 patients, 433 received education. The overall compliance rate was 73.6%, which was significantly higher in the subjects with a short duration or living in a rural area compared to those with a long duration (85.0% vs. 65.1%, respectively; P<0.001) or living in an urban area (78.2% vs. 70.4%, respectively; P=0.037). The hemoglobin A1c decreased greater in the compliant group (from 7.84±1.54 at baseline to 6.79±1.06 at 3 months and 6.97±1.20 at 12 months after prescription in the compliant group vs. from 7.74±1.25 to 7.14±1.02 and 7.24±1.24 in the non-compliant group; P=0.001). The decrease in hemoglobin A1c was greater in the subjects with a short duration (P=0.032).

Conclusion

In our study a large percent of patients refuse to get education despite having a prescription from their physician. This refusal rate was higher in the patients with long-standing diabetes or in urban residence. Furthermore, education was more effective in patients with a short duration of diabetes in clinical practice.

Citations

Citations to this article as recorded by

Clinical Effects of a Home Care Pilot Program for Patients with Type 1 Diabetes Mellitus: A Retrospective Cohort Study
Sejeong Lee, KyungYi Kim, Ji Eun Kim, Yura Hyun, Minyoung Lee, Myung-Il Hahm, Sang Gyu Lee, Eun Seok Kang
Diabetes & Metabolism Journal.2023; 47(5): 693. CrossRef
Management Status of Patients with Type 2 Diabetes Mellitus at General Hospitals in Korea: A 5-Year Follow-Up Study
Jin Hee Jung, Jung Hwa Lee, Hyang Mi Jang, Young Na, Hee Sun Choi, Yeon Hee Lee, Yang Gyo Kang, Na Rae Kim, Jeong Rim Lee, Bok Rye Song, Kang Hee Sim
The Journal of Korean Diabetes.2022; 23(1): 64. CrossRef
The Effectiveness of Multidisciplinary Team-Based Education in the Management of Type 2 Diabetes
Jong Ho Kim, Yun Jeong Nam, Won Jin Kim, Kyung Ah Lee, A Ran Baek, Jung Nam Park, Jin Mi Kim, Seo Young Oh, Eun Heui Kim, Min Jin Lee, Yun Kyung Jeon, Bo Hyun Kim, In Joo Kim, Yong Ki Kim, Sang Soo Kim
The Journal of Korean Diabetes.2018; 19(2): 119. CrossRef
The diabetes self-management educational programs and their integration in the usual care: A systematic literature review
Emmanuel Kumah, Giulia Sciolli, Maria Laura Toraldo, Anna Maria Murante
Health Policy.2018; 122(8): 866. CrossRef
Diabetes Camp as Continuing Education for Diabetes Self-Management in Middle-Aged and Elderly People with Type 2 Diabetes Mellitus
So Young Park, Sun Young Kim, Hye Mi Lee, Kyu Yeon Hur, Jae Hyeon Kim, Moon-Kyu Lee, Kang-Hee Sim, Sang-Man Jin
Diabetes & Metabolism Journal.2017; 41(2): 99. CrossRef
Educational attainment moderates the associations of diabetes education with health outcomes
Su Hyun Kim
International Journal of Nursing Practice.2016; 22(5): 444. CrossRef
Experiences of Diabetes Education among Educators of Diabetes : a content analysis approach
Soo Jin Kang, Soo Jung Chang
Journal of Korean Public Health Nursing.2016; 30(2): 221. CrossRef
Barrier Factors to the Completion of Diabetes Education in Korean Diabetic Adult Patients: Korea National Health and Nutrition Examination Surveys 2007-2012
Hee-Tae Kim, Kiheon Lee, Se Young Jung, Seung-Min Oh, Su-Min Jeong, Yoon-Jung Choi
Korean Journal of Family Medicine.2015; 36(5): 203. CrossRef
Determinants of glycaemic control in a practice setting: the role of weight loss and treatment adherence (The DELTA Study)
C. McAdam‐Marx, B. K. Bellows, S. Unni, J. Mukherjee, G. Wygant, U. Iloeje, J. N. Liberman, X. Ye, F. J. Bloom, D. I. Brixner
International Journal of Clinical Practice.2014; 68(11): 1309. CrossRef
Health education via mobile text messaging for glycemic control in adults with type 2 diabetes: A systematic review and meta-analysis
Mohsen Saffari, Ghader Ghanizadeh, Harold G. Koenig
Primary Care Diabetes.2014; 8(4): 275. CrossRef
The Appropriateness of the Length of Insulin Needles Based on Determination of Skin and Subcutaneous Fat Thickness in the Abdomen and Upper Arm in Patients with Type 2 Diabetes
Kang Hee Sim, Moon Sook Hwang, Sun Young Kim, Hye Mi Lee, Ji Yeun Chang, Moon Kyu Lee
Diabetes & Metabolism Journal.2014; 38(2): 120. CrossRef
Diabetes Attitudes, Wishes and Needs second study (DAWN2™): Cross‐national benchmarking of diabetes‐related psychosocial outcomes for people with diabetes
A. Nicolucci, K. Kovacs Burns, R. I. G. Holt, M. Comaschi, N. Hermanns, H. Ishii, A. Kokoszka, F. Pouwer, S. E. Skovlund, H. Stuckey, I. Tarkun, M. Vallis, J. Wens, M. Peyrot
Diabetic Medicine.2013; 30(7): 767. CrossRef

Low Density Lipoprotein Cholesterol Target Goal Attainment Rate and Physician Perceptions about Target Goal Achievement in Korean Patients with Diabetes: Jenie Yoonoo Hwang, Chang Hee Jung, Woo Je Lee, Cheol Young Park, Sung Rae Kim, Kun-Ho Yoon, Moon Kyu Lee, Sung Woo Park, Joong-Yeol Park; Diabetes Metab J. 2011;35(6):628-636. Published online December 26, 2011; DOI: https://doi.org/10.4093/dmj.2011.35.6.628

4,711 View
43 Download
20 Crossref

Abstract PDF PubReader

Background

This study aims to investigate the discrepancy between clinicians' perceptions and actual achievement rates of low density lipoprotein cholesterol (LDL-C) in Korean patients with diabetes according to updated American Diabetes Association (ADA)/American College of Cardiology Foundation (ACC) recommendations.

Methods

This is a multi-center, retrospective, non-interventional, observational study. Diabetic patients aged 18 years or older were eligible if they had been diagnosed with hypercholesterolemia or were receiving a lipid-lowering therapy between May 2010 and August 2010. The information was obtained by reviewing medical records and using a self-completed questionnaire to examine physician perceptions.

Results

A total of 2,591 subjects who satisfied the inclusion criteria were enrolled. Highest-risk and high-risk patients accounted for 61.9% and 38.1% of the patients, respectively. Although most (96.3%) underwent a statin monotherapy or a statin-based combination therapy, just 47.4% of patients attained the LDL-C target. However, the physicians' perceptions on target achievement rate (70.6%) were different from the actual results (47.4%). Many patients (65.3%) remained on the starting doses of statins, despite evidence of poor achievement of lipid goals.

Conclusion

Only less than half of patients with diabetes attained the LDL-C goal. The surveys showed that poor physician performance might be due to the lack of recognition on ADA/ACC consensus causing a low LDL-C target attainment rate. Therefore, changes in doctor perception are needed to attain target LDL-C level and reduce cardiovascular risk in Korean patients with diabetes.

Citations

Citations to this article as recorded by

Lipid Management in Korean People With Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement
Ye Seul Yang, Hack-Lyoung Kim, Sang-Hyun Kim, Min Kyong Moon
Journal of Lipid and Atherosclerosis.2023; 12(1): 12. CrossRef
Lipid Management in Korean People with Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement
Ye Seul Yang, Hack-Lyoung Kim, Sang-Hyun Kim, Min Kyong Moon
Diabetes & Metabolism Journal.2023; 47(1): 1. CrossRef
Impact of physician's perception about LDL cholesterol control in clinical practice when treating patients in Spain
Juan Cosín-Sales, Raquel Campuzano Ruiz, José Luis Díaz Díaz, Carlos Escobar Cervantes, María Rosa Fernández Olmo, Juan José Gómez-Doblas, José María Mostaza, Juan Pedro-Botet, Núria Plana Gil, Pedro Valdivielso
Atherosclerosis.2023; 375: 38. CrossRef
Current Status of Low-Density Lipoprotein Cholesterol Target Achievement in Patients with Type 2 Diabetes Mellitus in Korea Compared with Recent Guidelines
Soo Jin Yun, In-Kyung Jeong, Jin-Hye Cha, Juneyoung Lee, Ho Chan Cho, Sung Hee Choi, SungWan Chun, Hyun Jeong Jeon, Ho-Cheol Kang, Sang Soo Kim, Seung-Hyun Ko, Gwanpyo Koh, Su Kyoung Kwon, Jae Hyuk Lee, Min Kyong Moon, Junghyun Noh, Cheol-Young Park, Sung
Diabetes & Metabolism Journal.2022; 46(3): 464. CrossRef
Lipid-lowering treatment intensity, persistence, adherence and goal attainment in patients with coronary heart disease
Faizan Mazhar, Paul Hjemdahl, Catherine M Clase, Kristina Johnell, Tomas Jernberg, Juan Jesus Carrero
American Heart Journal.2022; 251: 78. CrossRef
Evaluation of efficacy and safety of combined rosuvastatin and atorvastatin in treating with coronary heart disease
Ke Li, Meng-Meng Liu, Xin Yang, Li Chen, Hui Geng, Wei Luo, Jie Ma
Medicine.2021; 100(24): e26340. CrossRef
Achievement of LDL-C Targets Defined by ESC/EAS (2011) Guidelines in Risk-Stratified Korean Patients with Dyslipidemia Receiving Lipid-Modifying Treatments
Ye Seul Yang, Seo Young Lee, Jung-Sun Kim, Kyung Mook Choi, Kang Wook Lee, Sang-Chol Lee, Jung Rae Cho, Seung-Jin Oh, Ji-Hyun Kim, Sung Hee Choi
Endocrinology and Metabolism.2020; 35(2): 367. CrossRef
Low-density lipoprotein cholesterol goal attainment rates in high-risk patients with cardiovascular diseases and diabetes mellitus in Korea: a retrospective cohort study
Ye Seul Yang, Bo Ram Yang, Mi-Sook Kim, Yunji Hwang, Sung Hee Choi
Lipids in Health and Disease.2020;[Epub] CrossRef
Dyslipidemia and Rate of Under-Target Low-Density Lipoprotein-Cholesterol in Patients with Coronary Artery Disease in Korea
Sang-Hak Lee, Woo-Hyuk Song, Myung Ho Jeong, Seung-Ho Hur, Dong Woon Jeon, Wonju Jeung, Anselm K Gitt, Martin Horack, Ami Vyas, Dominik Lautsch, Baishali Ambegaonkar, Philippe Brudi, Yangsoo Jang
Journal of Lipid and Atherosclerosis.2019; 8(2): 242. CrossRef
Statin use and site-specific risk of colorectal cancer in individuals with hypercholesterolemia from the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS)
Jae-Woo Lee, Na-Young You, Yeseul Kim, Yonghwan Kim, Joungyoun Kim, Hee-Taik Kang
Nutrition, Metabolism and Cardiovascular Diseases.2019; 29(7): 701. CrossRef
Efficacy and safety of rosuvastatin versus atorvastatin in high-risk Chinese patients with hypercholesterolemia: a randomized, double-blind, active-controlled study
Shuiping Zhao, Daoquan Peng
Current Medical Research and Opinion.2018; 34(2): 227. CrossRef
Effect of physician characteristics and knowledge on the quality of dyslipidemia management and LDL–C target goal achievement in China: Subgroup analysis of the Dyslipidemia International Study
Rongjing Ding, Ping Ye, Shuiping Zhao, Dong Zhao, Xiaowei Yan, Yugang Dong, Jihu Li, Yuqin Ran, Dayi Hu
Journal of Global Health.2017;[Epub] CrossRef
Trends in the management levels of metabolic risk factors in middle-aged and elderly patients with type 2 diabetes mellitus: The Korean National Health and Nutrition Examination Survey 1998–2014
Sukyung Cho, Haeun Jang, Kyong Park, Stefan Kiechl
PLOS ONE.2017; 12(12): e0189361. CrossRef
Increased postprandial apolipoprotein B-48 level after a test meal in diabetic patients: A multicenter, cross-sectional study
Cheol-Young Park, Joong-Yeol Park, Jongwon Choi, Dae Jung Kim, Kyong Soo Park, Kun-Ho Yoon, Moon-Kyu Lee, Sung-Woo Park
Metabolism.2016; 65(6): 843. CrossRef
Physicians’ behavior following changes in LDL cholesterol target goals
Shlomo Vinker, Haim Bitterman, Doron Comaneshter, Arnon D Cohen
Israel Journal of Health Policy Research.2015;[Epub] CrossRef
Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: Results of the DYSlipidemia International Study (DYSIS)
Shuiping Zhao, Yongjun Wang, Yiming Mu, Bilian Yu, Ping Ye, Xiaowei Yan, Zhanquan Li, Yidong Wei, Baishaili M. Ambegaonakr, Dayi Hu
Atherosclerosis.2014; 235(2): 463. CrossRef
First-line treatment patterns and lipid target levels attainment in very high cardiovascular risk outpatients
Ioanna Xanthopoulou, Periklis Davlouros, Simos Siahos, Angelos Perperis, Evangelia Zaharioglou, Dimitrios Alexopoulos
Lipids in Health and Disease.2013;[Epub] CrossRef
Statin Prescription Adhered to Guidelines for Patients Hospitalized due to Acute Ischemic Stroke or Transient Ischemic Attack
Keun-Sik Hong, Mi Sun Oh, Hye-Yeon Choi, A-Hyun Cho, Hyung-Min Kwon, Kyung-Ho Yu, Hee-Joon Bae, Juneyoung Lee, Byung-Chul Lee
Journal of Clinical Neurology.2013; 9(4): 214. CrossRef
LDL-cholesterol target values and actual values in patients with type 2 diabetes (T2D) uncontrolled on oral antidiabetic monotherapy: The lipid results of the French ESCALADE survey
Alfred Penfornis, Alain Baleydier, Thierry Clavel, Sylvie Picard
Annales d'Endocrinologie.2012; 73(6): 503. CrossRef
Clinical evaluation of the use of statins in diabetic dyslipidemia
김나영, 류재곤, 정효근, 백소영, 남상민
Journal of Korean Society of Health-System Pharmacists.2012; 29(3): 288. CrossRef

Management of Blood Pressure in Patients with Type 2 Diabetes Mellitus: A Nationwide Survey in Korean: Mi Hae Seo, Woo Je Lee, Cheol Young Park, Sung Rae Kim, Joong Yeol Park, Kun-Ho Yoon, Moon Kyu Lee, Sung Woo Park; Diabetes Metab J. 2011;35(4):348-353. Published online August 31, 2011; DOI: https://doi.org/10.4093/dmj.2011.35.4.348

4,372 View
34 Download
5 Crossref

Abstract PDF PubReader

Background

Hypertension is common in patients with type 2 diabetes, affecting up to 60% of patients. The Korean Diabetes Association performed a nationwide survey about prevalence, awareness and control of hypertension among diabetic Koreans.

Methods

The current survey included 3,859 diabetic patients recruited from 43 hospitals in Korea. Age, gender, height, weight and blood pressure (BP) were measured by standard methods. Data on fasting plasma glucose, glycosylated hemoglobin (HbA1c), awareness of hypertension, and compliance of antihypertensive medication were collected via interview and reviewed using patient medical records.

Results

A total of 57.5% of all patients were >60 years old. Their mean HbA1c was 7.6±1.5%. Among antihypertensive medication users, 39.9% had <130 mm Hg and <80 mm Hg, whereas 60.1% had ≥130 mm Hg or ≥80 mm Hg. The answer "BP is under good control" was given by 75.1% of the antihypertensive medication users. Out of these patients, 26.4% had <130 mm Hg and <80 mm Hg, whereas 73.6% had ≥130 mm Hg or ≥80 mm Hg. A total of 75.5% of antihypertensive medication users answered that they had taken their antihypertensive medication every day for the past 2 weeks. "Forgetfulness" was most frequently the reason of non-compliance for patients that did not take their antihypertensive medication regularly.

Conclusion

Approximately one third of the patients with diabetes were found to reach target blood pressure control in the 43 hospitals across Korea. Stricter control is needed to reduce severe complications of diabetes in Korea.

Citations

Citations to this article as recorded by

Value of ambulatory blood pressure measurement in diagnosing hypotension in hypertensive diabetic patients with medication-controlled BP
Kamal Alghalayini
JRSM Cardiovascular Disease.2020; 9: 204800402093088. CrossRef
Association between blood pressure and target organ damage in patients with chronic kidney disease and hypertension: results of the APrODiTe study
Ran-hui Cha, Sejoong Kim, Sun Ae Yoon, Dong-Ryeol Ryu, Ji Eun Oh, Sang-Youb Han, Eun Young Lee, Dong Ki Kim, Yon Su Kim
Hypertension Research.2014; 37(2): 172. CrossRef
Blood Pressure Control According to the Prevalence of Diabetes in Renal Transplant Recipients
E. Zbroch, J. Malyszko, I. Glowinska, D. Maciorkowska, G. Kobus, M. Mysliwiec
Transplantation Proceedings.2013; 45(1): 200. CrossRef
Prevalence, awareness, treatment and control of hypertension in adults with diagnosed diabetes: The Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV)
H-S Lee, S-S Lee, I-Y Hwang, Y-J Park, S-H Yoon, K Han, J-W Son, S-H Ko, Y G Park, H W Yim, W-C Lee, Y-M Park
Journal of Human Hypertension.2013; 27(6): 381. CrossRef
Multi-Institutional Analysis of Localized Renal Cell Carcinoma that Demonstrates the Impact of Diabetic Status on Prognosis After Nephrectomy
Yun-Sok Ha, Won Tae Kim, Seok-Joong Yun, Sang-Cheol Lee, Wun-Jae Kim, Yong Hyun Park, Seok Ho Kang, Sung-Hoo Hong, Seok-Soo Byun, Yong-June Kim
Annals of Surgical Oncology.2013; 20(11): 3662. CrossRef

Author index